{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:11:41Z","timestamp":1794276701513,"version":"4.9.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","award":["DNRF148"],"award-info":[{"award-number":["DNRF148"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.cgh.2023.06.025","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T11:46:01Z","timestamp":1689075961000},"page":"135-143.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0405-7250","authenticated-orcid":false,"given":"Daniel","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nynne","family":"Nyboe Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"G\u00f8rtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aske","family":"Thorn Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"H\u00f8jgaard Allin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Beaugerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Kirchgesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Jess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2023.06.025_bib1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2023.06.025_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: a comprehensive review","volume":"60","author":"Alikhan","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.cgh.2023.06.025_bib3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3389\/fimmu.2019.00382","article-title":"Anti-TNF therapy in spondyloarthritis and related diseases, impact on the immune system and prediction of treatment responses","volume":"10","author":"Menegatti","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.cgh.2023.06.025_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/apt.13835","article-title":"Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014","volume":"45","author":"Kirchgesner","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.06.025_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000239","article-title":"Paradoxical reactions under TNF-\u03b1 blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview","volume":"2","author":"Toussirot","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.cgh.2023.06.025_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/1403494815575193","article-title":"Danish nationwide registers for public health and health-related research","volume":"43","author":"Erlangsen","year":"2015","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.cgh.2023.06.025_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.cgh.2023.06.025_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.cgh.2023.06.025_bib9","doi-asserted-by":"crossref","first-page":"dyw213","DOI":"10.1093\/ije\/dyw213","article-title":"Data resource profile: the Danish National Prescription Registry","volume":"46","author":"Potteg\u00e5rd","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.cgh.2023.06.025_bib10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cgh.2023.06.025_bib11","doi-asserted-by":"crossref","first-page":"h2809","DOI":"10.1136\/bmj.h2809","article-title":"Association between tumour necrosis factor-\u03b1 inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study","volume":"350","author":"Andersen","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2023.06.025_bib12","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1001\/jama.2014.5613","article-title":"Association between tumor necrosis factor-\u03b1 antagonists and risk of cancer in patients with inflammatory bowel disease","volume":"311","author":"Andersen","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2023.06.025_bib13","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.2017.16071","article-title":"Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease","volume":"318","author":"Lemaitre","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2023.06.025_bib14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/00365529609031980","article-title":"Assessment of the diagnoses of Crohn\u2019s disease and ulcerative colitis in a Danish hospital information system","volume":"31","author":"Fonager","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.06.025_bib15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrgastro.2013.117","article-title":"Extraintestinal manifestations and complications in IBD","volume":"10","author":"Ott","year":"2013","journal-title":"Nature Reviews Gastroenterology and Hepatology [Internet"},{"key":"10.1016\/j.cgh.2023.06.025_bib16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2340\/00015555-3278","article-title":"Validation of psoriasis diagnoses in the Danish National Patient Register","volume":"99","author":"Loft","year":"2019","journal-title":"Acta Dermato Venereologica"},{"key":"10.1016\/j.cgh.2023.06.025_bib17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2147\/CLEP.S141438","article-title":"Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry","volume":"9","author":"Ibfelt","year":"2017","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.cgh.2023.06.025_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behavioral Research"},{"key":"10.1016\/j.cgh.2023.06.025_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/096228029300200202","article-title":"The statistical basis of meta-analysis","volume":"2","author":"Fleiss","year":"1993","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.cgh.2023.06.025_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1524-4733.2009.00671.x","article-title":"Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals","volume":"13","author":"Xu","year":"2010","journal-title":"Value Health"},{"key":"10.1016\/j.cgh.2023.06.025_bib21","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/EDE.0000000000000864","article-title":"Website and R package for computing E-values","volume":"29","author":"Mathur","year":"2018","journal-title":"Epidemiology"},{"key":"10.1016\/j.cgh.2023.06.025_bib22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2023.06.025_bib24","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1001\/jamainternmed.2015.5396","article-title":"Risk of demyelinating diseases in the central nervous system in patients with inflammatory bowel disease treated with tumor necrosis factor inhibitors","volume":"175","author":"Andersen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cgh.2023.06.025_bib25","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/00042737-200012080-00004","article-title":"Smoking and inflammatory bowel disease","volume":"12","author":"Rubin","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.06.025_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.cgh.2023.06.025_bib27","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.dld.2019.01.024","article-title":"Impact of inflammatory bowel diseases on working life: a French nationwide survey","volume":"51","author":"le Berre","year":"2019","journal-title":"Digestive and Liver Disease [Internet"},{"key":"10.1016\/j.cgh.2023.06.025_bib28","first-page":"163","article-title":"The rising burden of inflammatory bowel disease in Denmark over two decades: a nationwide cohort study","author":"Agrawal","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.06.025_bib29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2147\/CLEP.S99478","article-title":"The Danish National Registry for Biological Therapy in Inflammatory Bowel Disease","volume":"8","author":"Larsen","year":"2016","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.cgh.2023.06.025_bib30","series-title":"Danish smoking habits 2020","year":"2021"},{"key":"10.1016\/j.cgh.2023.06.025_bib31","first-page":"132","article-title":"Consommation de Tabac parmi les adultes en 2020: Resultats de barom\u00e8tre de Sant\u00e9 Publique France\/Tobacco use among adults in 2020\u2014results from the Sant\u00e9 Publique France Health Barometer","volume":"8","author":"Pasquereau","year":"2021","journal-title":"Bulletin \u00e9pid\u00e9miologique hebdomadaire"},{"key":"10.1016\/j.cgh.2023.06.025_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autrev.2013.06.005","article-title":"Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-\u03b1 agents","volume":"13","author":"Fiorino","year":"2014","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.cgh.2023.06.025_bib33","first-page":"2569","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum 2010"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523005323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523005323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:44:45Z","timestamp":1761543885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356523005323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1542356523005323"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2023.06.025","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2023.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the AGA Institute","name":"copyright","label":"Copyright"}]}}